Projects per year
Abstract
Bullous pemphigoid (BP) is the most common autoimmune skin blistering disease characterized by autoimmunity against the hemidesmosomal proteins BP180, type XVII collagen, and BP230. To elucidate the genetic basis of susceptibility to BP, we performed the first genome-wide association study (GWAS) in Germans. This GWAS was combined with HLA locus targeted sequencing in an additional independent BP cohort. The strongest association with BP in Germans tested in this study was observed in the two HLA loci, HLA-DQA1*05:05 and HLA-DRB1*07:01. Further studies with increased sample sizes and complex studies integrating multiple pathogenic drivers will be conducted.
| Original language | English |
|---|---|
| Article number | 228 |
| Journal | Orphanet Journal of Rare Diseases |
| Volume | 16 |
| Issue number | 1 |
| Pages (from-to) | 228 |
| ISSN | 1750-1172 |
| DOIs | |
| Publication status | Published - 19.05.2021 |
Funding
This work was supported by the Germany Research Council (Deutsche Forschungsgemeinschaft, DFG) through the Clinical Research Unit 303 Pemphigoid Diseases (to NvB, IRK, JEr, HB, CDS, MHi, DZ, ES, and SMI). The authors would like to extend their gratitude towards all patients for their participation in this study. We are also grateful to the numerous study nurses, physicians, and technicians of the study centres who were involved in patient recruitment, sample storage, and sample shipping. We also thank the German Autoimmune Bullous Disease Study Group.
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
- Centers: Center for Research on Inflammation of the Skin (CRIS)
DFG Research Classification Scheme
- 2.21-05 Immunology
- 2.22-19 Dermatology
- 2.11-05 General Genetics and Functional Genome Biology
Fingerprint
Dive into the research topics of 'Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans'. Together they form a unique fingerprint.Projects
- 1 Finished
-
CRU 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential
Sadik, C. (Speaker, Coordinator), Zillikens, D. (Speaker, Coordinator), Ibrahim, S. (Principal Investigator (PI)), Baines, J. F. (Principal Investigator (PI)), Schmidt, E. (Principal Investigator (PI)), Köhl, J. (Principal Investigator (PI)), Ehlers, M. (Principal Investigator (PI)), Hirose, M. (Principal Investigator (PI)), König, P. (Principal Investigator (PI)), Ludwig, R. (Principal Investigator (PI)), Manz, R. (Principal Investigator (PI)), Schwaninger, M. (Principal Investigator (PI)), Beek, N. (Principal Investigator (PI)), Erdmann, J. (Principal Investigator (PI)), König, I. R. (Principal Investigator (PI)), Verschoor, A. (Principal Investigator (PI)), Karsten, C. (Principal Investigator (PI)), Bieber, K. (Principal Investigator (PI)) & Busch, H. S. (Principal Investigator (PI))
01.04.15 → 31.12.23
Project: DFG Joint Research › DFG Clinical Research Units (CRU)